Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-005228
Filing Date
2022-05-12
Accepted
2022-05-12 14:30:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29982
2 filename2.txt TEXT-EXTRACT 5561
  Complete submission text file 0000000000-22-005228.txt   47610
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filed for) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations